CAS Number: 1297538-32-9

Stage: Pipeline

Darolutamide is a non-steroidal androgen receptor antagonist used in non-metastatic castration-resistant prostate cancer (nmCRPC). It has a unique chemical structure with low blood-brain barrier penetration, reducing CNS side effects. Darolutamide is known for its efficacy, safety, and improved quality of life in prostate cancer patients. Explore Royal Pharma as your potential partner for Darolutamide API.